Danish biotechnology firm Orphazyme, which develops medication for rare diseases, forecasts an operating deficit at DKK 100m-150m (USD 16.2m-24.2m) in 2021, which is significantly lower than the realized deficit for 2020 at DKK 608m, according to the firm's 2020 annual report.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Board chair at Coloplast and Lundbeck warns against large pay rises
Companies have a responsibility to help combat inflation by keeping pay rises in check during contract negotiations, says Lars Rasmussen.
Ellab slapped with customs fine over US imports
Danish medtech producer Ellab broke US customs rules and is now paying the price.
China approves Y-mabs drug
Y-mabs’ cancer treatment Danyelza, which is currently licensed to Sciclones, has been approved by the Chinese authorities. Y-mabs will receive double-digit sales royalties.
CEO gets "taste of own medicine" by participating in vaccine trial
Expres2ion CEO Bent U. Frandsen is one of 3,000 volunteers participating in a phase III trial of Bavarian Nordic’s Covid-19 booster candidate. If the vaccine reaches the market, Expres2ion will be entitled to royalties.
FDA approves Covid-19 jabs as boosters for infants
The US Food and Drug Administration has approved the use of Moderna and Pfizer/Biontech’s coronavirus vaccines as boosters for children as young as six months old.
Director, QA Commercial Drug Substance, Ascendis Pharma 
Specialist, Regulatory Affairs 
Medical Director 
Chief consultant for Dansk Erhvervs Health and life science 
Principal Systems Engineer 
Head of Engineering 
Research Scientist, Immunology/Translational Research 
Head of Regulatory Affairs Danmark 
Supply Chain Manager 
Senior or Principal Scientist – Preclinical Biology 
Consultants for FIERS - will you create unique healthcare collaborations? - FIERS - Copenhagen / Denmark